Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorAllegue, F. (F.)-
dc.creatorBoixeda, P. (Pablo)-
dc.creatorEspaña, A. (Agustín)-
dc.creatorMoreno, R. (R.)-
dc.creatorLedo, A. (Antonio)-
dc.date.accessioned2013-04-15T08:08:55Z-
dc.date.available2013-04-15T08:08:55Z-
dc.date.issued1989-
dc.identifier.citationAllegue F, Boixeda P, España A, Moreno R, Ledo A. Síndrome de Reiter exacerbado por indometacina. Med Cutan Ibero Lat Am. 1989;17(2):113-6.es_ES
dc.identifier.issn0210-5187-
dc.identifier.urihttps://hdl.handle.net/10171/28279-
dc.description.abstractA 26-year-old man, with a personal history of drug abuse and positive serology for HIV, had Reiter's syndrome for six years. He experienced progressive worsening of his cutaneous lesions after initiation of indomethacin therapy. The skin lesions were almost completely resolved after the discontinuance of the drug and its reintroduction resulted in a similar deterioration. To our knowledge, indomethacin has not been reported to aggravate Reiter's syndrome. This case study documents anti-inflammatory drugs as possible causal factors for triggering Reiter's syndrome. Possible implicated mechanisms are also discussed.es_ES
dc.language.isospaes_ES
dc.publisherDoymaes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectHIV Seropositivity/complicationses_ES
dc.subjectIndomethacin/adverse effectses_ES
dc.subjectSkin Diseases/pathologyes_ES
dc.titleSíndrome de Reiter exacerbado por indometacinaes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.driverinfo:eu-repo/semantics/articlees_ES

Ficheros en este ítem:
Vista previa
Fichero
Med_Cutan_Ibero_Lat_Am_1989_17(2)_113-116.pdf
Descripción
Tamaño
264.95 kB
Formato
Adobe PDF


Estadísticas e impacto
0 citas en
0 citas en

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.